logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for global professionals · Tuesday, June 3, 2025 · 818,701,753 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Companies News  •••  Topics  •  Countries  •  U.S. States

3SBio Cancer News Monitoring

  • Published on Jun 2, 2025

    Bristol Myers allies with BioNTech on bispecific cancer drug

    Bristol Myers Squibb is making sure it won’t miss out on a new type of cancer immunotherapy that’s drawn immense industry interest, announcing Monday an alliance with BioNTech on a bispecific antibody the German biotechnology company is developing.  Dubbed …

    Source: BioPharma Dive - Pending
  • Published on Jun 2, 2025

    BioNTech flips its cancer bispecific to BMS for a big profit

    Bristol Myers Squibb has reached for its wallet to avoid being left behind in the race to develop a new class of bispecific antibodies for cancer that have been billed as the next big thing in immunotherapy. It has licensed a PD-L1xVEGF bispecific antibody …

    Source: pharmaphorum - Neutral
  • Published on Jun 2, 2025

    BMS Commits up to $11B+ To Work With BioNTech on Solid Tumor Bispecific

    Just over six months after BioNTech bought out its development partner Biotheus to acquire solid tumor bispecific BNT327, Bristol Myers Squibb is dropping $1.5 billion upfront plus another $2 billion in noncontingent payments and up to $7.6 billion more in …

    Source: BioSpace - Pending
  • Published on Jun 2, 2025

    Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy

    Audio By Carbonatix By Ludwig Burger and Michael Erman (Reuters) -Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany’s BioNTech and develop the latter’s next-generation cancer immunotherapy, which could take on rival Merck …

    Source: SRN News - Center-right
  • Published on Jun 2, 2025

    BioNTech stock jumps as Bristol agrees to $11.1B cancer drug deal

    (Bloomberg) — Bristol-Myers Squibb Co. (BMY) will pay BioNTech SE (BNTX) as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune system to attack tumors. Most …

    Source: Yahoo Finance - Center-left
  • Published on Jun 2, 2025

    US manufacturing activity contracted in May — for a third month

    ECONOMY US manufacturing activity contracted in May — for a third month US factory activity contracted in May for a third consecutive month and a gauge of imports fell to a 16-year low as firms pulled back in the face of higher tariffs. The Institute for …

    Source: The Boston Globe - Massachusetts - Neutral
  • Published on Jun 2, 2025

    Bispecific competition, debating oral SERDs and a bold GLP-1 prediction

    CHICAGO — The American Society of Clinical Oncology’s annual meeting is a forum for data. On Monday, it was also the backdrop to oncology’s latest deal, when Bristol Myers Squibb and BioNTech announced a multibillion-dollar alliance around a newly in-vogue …

    Source: BioPharma Dive - Pending
  • Published on Jun 2, 2025

    Top biotech deals in May 2025

    Newsletter Signup - Under Article / In Page "*" indicates required fields The month of May was a quieter one on the deals front compared to the past few months this year. Still, biopharmas got together to fuel the RNA and small molecule …

    Source: Labiotech - Neutral
  • Published on Jun 1, 2025

    A funding flashpoint, Pfizer’s $1B poster and AstraZeneca advertising

    Funding cancer research isn't usually a political flashpoint. But as the Trump administration signals its desire to drastically cut the budget of the National Cancer Institute, the American Society of Clinical Oncology is finding itself forced to …

    Source: BioPharma Dive - Pending
  • Published on May 31, 2025

    At ASCO 2025, attendees see reason for hope, despite worries

    For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here. The annual meeting of the American Society of Clinical Oncology is now in session. As always, STAT has your appetite for cancer news covered. Reporters Matt …

    Source: STAT - Massachusetts - Neutral
  • Published on May 30, 2025

    Astellas Keeps Chinese Collab Train Chugging With $1.5B+ Bet for Claudin ADC

    Astellas Pharma on Thursday inked an exclusive licensing agreement with Suzhou-based Evopoint Biosciences to advance a novel antibody-drug conjugate targeting solid tumors. As per the terms of the agreement, Astellas will front $130 million while also …

    Source: BioSpace - Pending
  • Published on May 30, 2025

    Biotech and AI: Is Trump shooting in America's tech foot? China surging ahead of US

    Despite President Trump’s pledges to boost American dominance in artificial intelligence (AI) and biotechnology, recent policy moves risk undermining US leadership just as China surges ahead. Trump’s administration has imposed sweeping restrictions on the …

    Source: Firstpost - Center-right
  • Published on May 29, 2025

    Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma

    The pharma giant Pfizer has bought international rights to the experimental cancer therapy and will take a $100 million equity stake in the Chinese drug developer Key Takeaways: The mega deal for rights to the Chinese biotech's cancer drug drove 3SBio…

    Source: Benzinga - Neutral
  • «
  • 1
  • »

  • 2
  • 2
  • 7
  • 7
days
  • 1
  • 1
  • 4
  • 4
hours
:
  • 3
  • 3
  • 4
  • 4
minutes
:
  • 5
  • 5
  • 2
  • 2
seconds

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
search news using your own keywords. There are 818,701,753 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Companies A-Z >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory >

Companies Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Companies Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Company News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement